Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
Primary liver cancer is a common kind of digestive cancers with high malignancy, causing 745,500 deaths each year. Hepatocellular carcinoma is the major pathological type of primary liver cancer. Traditional treatment methods for patients with hepatocellular carcinoma have shown poor efficacy in kil...
Main Authors: | Yingjun Xie, Yien Xiang, Jiyao Sheng, Dan Zhang, Xiaoxiao Yao, Yongsheng Yang, Xuewen Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2018/8740976 |
Similar Items
-
Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects
by: Zhuoyan Liu, et al.
Published: (2021-10-01) -
Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
by: Cheng Zhong, et al.
Published: (2021-03-01) -
Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives
by: Weiqi Xu, et al.
Published: (2019-07-01) -
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma
by: Gok Yavuz B, et al.
Published: (2021-09-01) -
Bioinformatic Analysis of Circular RNA-Associated ceRNA Network Associated with Hepatocellular Carcinoma
by: Jiacheng Wu, et al.
Published: (2019-01-01)